Importantly, we further found that lower plasma Aβ42/Aβ40 predicted longitudinal neurodegeneration and cognitive decline in APOE-ε4 carriers only, but did not show significant predictive effect in APOE-ε4 non-carriers over around 5–6 years of median follow-up. Here, APOE is linked to Mental deterioration.